The Partch laboratory research is focused on identifying the fundamental basis of crosstalk between the circadian clock and DNA damage checkpoint response to understand how disruption of the clock regulates oncogenesis. They will achieve this by integrating diverse experimental approaches from cell biology to solution NMR spectroscopy to gain an atomic-level understanding of the clock, as well as providing new targets and/or a temporal basis for improved therapeutic intervention in cancer.